Abstract
Thyroid cancer is the most common endocrine malignancy and its incidence has been increasing considerably in the past few decades. Many studies have been published providing evidence for this increase; however, why thyroid cancer incidence keeps rising is still debated and there are conflicting reports of factors leading to the increase in its incidence. In this article, Nature Reviews Endocrinology asks four experts their opinions on some of the controversies surrounding the changing trends in thyroid cancer incidence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Takebe, K. et al. Mass screening for thyroid cancer by ultrasonography [Japanese]. KARKINOS 7, 309–317 (1994).
Thorvaldsson, S. E., Tulinius, H., Björnsson, J. & Bjarnason, O. Latent thyroid carcinoma in Iceland at autopsy. Pathol. Res. Pract. 188, 747–750 (1992).
SEER Cancer Statistics Review, 1975–2008. National Cancer Institute Surveillance Epidemiology and End Results [online], (2011).
Hughes, D. T., Haymart, M. R., Miller, B. S., Gauger, P. G. & Doherty, G. M. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21, 231–236 (2011).
Burgess, J. R. Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12, 141–149 (2002).
Davies, L. & Welch, H. G. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295, 2164–2167 (2006).
Leenhardt, L., Grosclaude, P., Cherie-Challine, L. & Thyroid Cancer Committee. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14, 1056–1060 (2004).
Kilfoy, B. A. et al. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20, 525–531 (2009).
Colonna, M. et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur. J. Cancer 43, 891–900 (2007).
Harach, H. R., Franssila, K. O. & Wasenius, V. M. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 56, 531–538 (1985).
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009).
Ito, Y. et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J. Surg. 34, 28–35 (2010).
Leenhardt, L. et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur. J. Endocrinol. 150, 133–139 (2004).
Sprague, B. L., Warren Andersen, S. & Trentham-Dietz, A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 19, 585–593 (2008).
Ezaki, H. et al. Analysis of thyroid carcinoma based on material registered in Japan during 1977–1986 with special reference to predominance of papillary type. Cancer 70, 808–814 (1992).
Mathur, A. et al. Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer 117, 4390–4395 (2011).
Cancer Facts & Figures 2011. American Cancer Society [online], (2011).
SEER Stat Fact Sheets: Thyroid. National Cancer Institute Surveillance Epidemiology and End Results [online], (2012).
Nakamura, T. et al. Statistics of descriptive epidemiology for death of malignant thyroid tumor in Japan [author's translation]. Kosei-no-Shihyo 41, 24–30 (1994).
Mazzaferri, E. L. & Jhiang, S. M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97, 418–428 (1994).
Noguchi, S., Yamashita, H., Uchino, S. & Watanabe, S. Papillary microcarcinoma. World J. Surg. 32, 747–753 (2008).
Cramer, J. D., Fu, P., Harth, K. C., Margevicius, S. & Wilhelm, S. M. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. Surgery 148, 1147–1152 (2010).
Enewold, L. et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol. Biomarkers Prev. 18, 784–791 (2009).
Ito, Y. et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13, 381–387 (2003).
Ron, E. et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 141, 259–277 (1995).
Dickman, P. W., Holm, L. E., Lundell, G., Boice, J. D. Jr & Hall, P. Thyroid cancer risk after thyroid examination with 131I: a population based cohort study in Sweden. Int. J. Cancer 106, 580–587 (2003).
Ito, Y. et al. Biological behavior and prognosis of familial thyroid carcinoma. Surgery 145, 100–105 (2009).
Huszno, B. et al. Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area. J. Endocrinol. Invest. 26, 71–76 (2003).
Cardis, E. et al. Risk of thyroid cancer after exposure to 131I in childhood. J. Natl Cancer Inst. 97, 724–732 (2005).
Negri, E. et al. A pooled analysis of case–control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10, 143–155 (1999).
Ron, E. et al. A population-based case–control study of thyroid cancer. J. Natl Cancer Inst. 79, 1–12 (1987).
Leung, A. M., Pearce, E. N. & Braverman, L. E. Perchlorate, iodine and the thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 24, 133–141 (2010).
Williams, D. Radiation carcinogenesis: lessons from Chernobyl. Oncogene 27 (Suppl. 2), S9–S18 (2008).
Dal Maso, L., Bosetti, C., La Vecchia, C. & Franceschi, S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20, 75–86 (2009).
Hieu, T. T. et al. Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis. Endocr. Relat. Cancer 19, 645–655 (2012).
American Thyroid Association (ATA) Policy Statement. American Thyroid Association [online], (2012).
Ward, M. H. et al. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 21, 389–395 (2010).
Pellegriti, G. et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J. Natl Cancer Inst. 101, 1575–1583 (2009).
Eze, O. P., Starker, L. F. & Carling, T. The role of epigenetic alterations in papillary thyroid carcinogenesis. J. Thyroid Res. 2011, 895470 (2011).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ito, Y., Nikiforov, Y., Schlumberger, M. et al. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol 9, 178–184 (2013). https://doi.org/10.1038/nrendo.2012.257
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2012.257
This article is cited by
-
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis
Journal of Endocrinological Investigation (2023)
-
Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case–control studies
European Journal of Nutrition (2022)
-
Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
European Journal of Nutrition (2022)
-
Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
Signal Transduction and Targeted Therapy (2021)
-
Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population
Endocrine (2021)